J Bone Metab.  2017 Feb;24(1):15-21. 10.11005/jbm.2017.24.1.15.

Coronary Artery Calcium Score and Bone Metabolism: A Pilot Study in Postmenopausal Women

• Salari P
• Keshtkar A
• Shirani S
• Mounesan L

• KMID: 2371828
• DOI: http://doi.org/10.11005/jbm.2017.24.1.15

Abstract

BACKGROUND
Since 1991 many studies evaluated the link between cardiovascular diseases and osteoporosis, two age-related conditions, but the main common pathologic pathway has not been determined yet. The histological similarity between arterial calcified plaque and bone matrix and involvement of similar cells and mediators provide a special field of research. Therefore in the present study, we aimed to evaluate the relationship between coronary artery calcium score (CACS) as a surrogate marker of atherosclerosis and bone mediators and parameters in postmenopausal women.
METHODS
Eleven postmenopausal women who had CACS higher than 80 were enrolled into the study and underwent bone densitometry. In addition, their serum and urine samples were taken for measuring osteoprotegerin, osteocalcin, and β cross laps. Patients' 10-year probability of fracture was calculated by the World Health Organization fracture-risk assessment tool (FRAX).
RESULTS
The regression analysis of our results showed the association between CACS and OC (std β=0.66, 95% confidence interval [CI] 5.47-72.27, P=0.027), femoral bone density (std β=−0.6, 95% CI -6864.34-14.27, P=0.05) and T-score (std β=−0.6, 95% CI −773.08-1.28, P=0.05) which remained significant after adjustment for age, weight, years since menopause and body mass index. No association was found between CACS and osteoprotegerin, spinal bone density and FRAX score.
CONCLUSIONS
In conclusion, this pilot study with small sample size showed the potential association between CACS and osteocalcin, femoral bone density and T-score. However, the relationship between CACS and osteoprotegerin, receptor activator of nuclear factor-kappa B ligand, FRAX score and other bone parameters remain to be clarified in larger sample size studies.

Keyword

Bone density; Calcium; Coronary artery disease; Osteocalcin; Osteoprotegerin

MeSH Terms

Atherosclerosis
Biomarkers
Body Mass Index
Bone Density
Bone Matrix
Calcium*
Cardiovascular Diseases
Coronary Artery Disease
Coronary Vessels*
Densitometry
Female
Humans
Menopause
Metabolism*
Osteocalcin
Osteoporosis
Osteoprotegerin
Pilot Projects*
RANK Ligand
Sample Size
World Health Organization
Biomarkers
Calcium
Osteocalcin
Osteoprotegerin
RANK Ligand

Reference

1. Salari P, Abdollahi M. A comprehensive review of the shared roles of inflammatory cytokines in osteoporosis and cardiovascular diseases as two common old people problem: actions toward development of new drugs. Int J Pharmacol. 2011; 7:552–567.

2. Nadra I, Mason JC, Philippidis P, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ Res. 2005; 96:1248–1256. PMID: 15905460.

3. Min H, Morony S, Sarosi I, et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med. 2000; 192:463–474. PMID: 10952716.

4. Khosla S, Amin S, Orwoll E. Osteoporosis in men. Endocr Rev. 2008; 29:441–464. PMID: 18451258.

5. Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001; 21:1998–2003. PMID: 11742876.

6. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation. 2007; 115:402–426. PMID: 17220398.

7. Krajnc M, Pečovnik-Balon B, Hojs R, et al. Comparison of coronary artery calcification and some coronary artery calcification risk factors in patients on haemodialysis and in patients with type 2 diabetes. J Int Med Res. 2011; 39:1006–1015. PMID: 21819735.

8. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990; 15:827–832. PMID: 2407762.

9. Kanis JA, McCloskey EV, Johansson H, et al. Development and use of FRAX in osteoporosis. Osteoporos Int. 2010; 21(Suppl 2):S407–S413. PMID: 20464374.

10. Bao Y, Zhou M, Lu Z, et al. Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men. Clin Endocrinol (Oxf). 2011; 75:196–201. PMID: 21521333.

11. Kim KJ, Kim KM, Park KH, et al. Aortic calcification and bone metabolism: the relationship between aortic calcification, BMD, vertebral fracture, 25-hydroxyvitamin D, and osteocalcin. Calcif Tissue Int. 2012; 91:370–378. PMID: 23052223.

12. Awan Z, Alwaili K, Alshahrani A, et al. Calcium homeostasis and skeletal integrity in individuals with familial hypercholesterolemia and aortic calcification. Clin Chem. 2010; 56:1599–1607. PMID: 20702785.

13. Wilund KR, Tomayko EJ, Evans EM, et al. Physical activity, coronary artery calcium, and bone mineral density in elderly men and women: a preliminary investigation. Metabolism. 2008; 57:584–591. PMID: 18328364.

14. Chen L, Li Q, Yang Z, et al. Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese. Diabet Med. 2013; 30:309–317. PMID: 22913521.

15. Sheng L, Cao W, Cha B, et al. Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2013; 12:22. PMID: 23342952.

16. Ogawa-Furuya N, Yamaguchi T, Yamamoto M, et al. Serum osteocalcin levels are inversely associated with abdominal aortic calcification in men with type 2 diabetes mellitus. Osteoporos Int. 2013; 24:2223–2230. PMID: 23563931.

17. Jono S, Ikari Y, Shioi A, et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation. 2002; 106:1192–1194. PMID: 12208791.

18. Ishiyama M, Suzuki E, Katsuda J, et al. Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients. Diabetes Res Clin Pract. 2009; 85:189–196. PMID: 19497632.

19. Asanuma Y, Chung CP, Oeser A, et al. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis. 2007; 195:e135–e141. PMID: 17570371.

20. Golledge J, McCann M, Mangan S, et al. Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke. 2004; 35:1636–1641. PMID: 15143295.

21. Quercioli A, Luciano Viviani G, Dallegri F, et al. Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification. Crit Pathw Cardiol. 2010; 9:227–230. PMID: 21119343.

22. Bakhireva LN, Laughlin GA, Bettencourt R, et al. Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification? J Clin Endocrinol Metab. 2008; 93:2009–2012. PMID: 18319315.

23. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res. 2004; 95:1046–1057. PMID: 15564564.

24. Barengolts EI, Berman M, Kukreja SC, et al. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int. 1998; 62:209–213. PMID: 9501953.

25. Hyder JA, Allison MA, Criqui MH, et al. Association between systemic calcified atherosclerosis and bone density. Calcif Tissue Int. 2007; 80:301–306. PMID: 17505774.

26. Celik C, Altunkan S, Yildirim MO, et al. Relationship between decreased bone mineral density and subclinical atherosclerosis in postmenopausal women. Climacteric. 2010; 13:254–258. PMID: 20082602.

27. Lee SH, Park SJ, Kim KN, et al. Coronary calcification Is reversely related with bone and hair calcium: the relationship among different calcium pools in body. J Bone Metab. 2016; 23:191–197. PMID: 27965940.

28. Choi SH, An JH, Lim S, et al. Lower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multidetector row coronary computed tomography in pre- and postmenopausal women. Clin Endocrinol (Oxf). 2009; 71:644–651. PMID: 19226260.

29. Farhat GN, Cauley JA, Matthews KA, et al. Volumetric BMD and vascular calcification in middle-aged women: the Study of Women's Health Across the Nation. J Bone Miner Res. 2006; 21:1839–1846. PMID: 17002567.

30. Lin T, Liu JC, Chang LY, et al. Association between coronary artery calcification using low-dose MDCT coronary angiography and bone mineral density in middle-aged men and women. Osteoporos Int. 2011; 22:627–634. PMID: 20552331.

31. Filgueira A, Carvalho AB, Tomiyama C, et al. Is coronary artery calcification associated with vertebral bone density in nondialyzed chronic kidney disease patients? Clin J Am Soc Nephrol. 2011; 6:1456–1462. PMID: 21617086.

32. Carr JJ, Register TC, Hsu FC, et al. Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: the diabetes heart study. Bone. 2008; 42:43–52. PMID: 17964237.

33. van der Klift M, Pols HA, Hak AE, et al. Bone mineral density and the risk of peripheral arterial disease: the Rotterdam Study. Calcif Tissue Int. 2002; 70:443–449. PMID: 11976772.

34. Bakhireva LN, Barrett-Connor EL, Laughlin GA, et al. Differences in association of bone mineral density with coronary artery calcification in men and women: the Rancho Bernardo Study. Menopause. 2005; 12:691–698. PMID: 16278612.

35. Ramsey-Goldman R, Manzi S. Association of osteoporosis and cardiovascular disease in women with systemic lupus erythematosus. Arthritis Rheum. 2001; 44:2338–2341. PMID: 11665974.

36. Koh JM, Khang YH, Jung CH, et al. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int. 2005; 16:1263–1271. PMID: 15702263.